Journal article
Alendronate for the Treatment of Osteoporosis in Men
Abstract
BACKGROUND: Despite its association with disability, death, and increased medical costs, osteoporosis in men has been relatively neglected as a subject of study. There have been no large, controlled trials of treatment in men.
METHODS: In a two-year double-blind trial, we studied the effect of 10 mg of alendronate or placebo, given daily, on bone mineral density in 241 men (age, 31 to 87 years; mean, 63) with osteoporosis. Approximately one …
Authors
Orwoll E; Ettinger M; Weiss S; Miller P; Kendler D; Graham J; Adami S; Weber K; Lorenc R; Pietschmann P
Journal
The New England Journal of Medicine, Vol. 343, No. 9, pp. 604–610
Publisher
Massachusetts Medical Society
Publication Date
August 31, 2000
DOI
10.1056/nejm200008313430902
ISSN
0028-4793